Lonza expands cell and gene therapy portfolio
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
Lonza boosts TheraPEAK line with new Cytokines and AAV Medium for next-gen therapies
Takeda will seek an external partner to leverage its cell therapy platform technologies
Through the new DTP platform, Novartis will make Cosentyx available to patients at a price that reflects the average savings typically retained by insurers and pharmacy benefit managers
BPDCN is a challenging blood cancer with characteristics of both leukemia and lymphoma
The platform integrates artificial intelligence into a unified environment that supports optical, microCT, ultrasound, and other imaging modalities
Amgen has invested over $40 billion in manufacturing and research and development in US since 2017
82,514 sq ft facility to host up to 15 biotech companies, fueling the development of next-generation medicines
Represents one of the largest cell culture biomanufacturing sites in North America, which will employ 1,400 people by 2031
Subscribe To Our Newsletter & Stay Updated